Therefore, the combined inhibition of PD-L1 and VEGF expression can effectively activate the immune response, promote the tumor infiltration effect of T cells, and inhibit tumor angiogenesis, making it an ideal target for combined therapy [10,19]. Here, VEGFA is linked to neoplasm.